ClinicalTrialsFinder

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS) Clinical Trials in Ulm

1 recruitingUlm, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Novartis Pharmaceuticals300 enrolled2 locationsNCT07498426